A clear trend in the ADC field is that the therapeutic target is moving from hematological tumors to solid tumors.
also in 12,254 other papers
Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.